VEN Stock Chart & Stats
€87.42
€2.88(3.41%)
At close: 4:00 PM EDT
€87.42
€2.88(3.41%)
Day’s Range― - ―
52-Week Range€56.16 - €87.98
Previous CloseN/A
Volume25.00
Average Volume (3M)29.00
Market Cap
€43.98B
Enterprise Value€52.84K
Total Cash (Recent Filing)€183.61M
Total Debt (Recent Filing)€12.73B
Price to Earnings (P/E)179.5
Beta0.07
Next Earnings
Jul 29, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.56
Shares Outstanding486,169,700
10 Day Avg. Volume41
30 Day Avg. Volume29
Financial Highlights & Ratios
PEG Ratio0.80
Price to Book (P/B)2.81
Price to Sales (P/S)6.04
P/FCF Ratio26.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€87.32Price Target Upside-0.11% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering16
EPS Forecast (FY)0.55
Revenue Forecast (FY)€5.97B
Bulls Say, Bears Say
Bulls Say
SHOP Same-store NOI & Occupancy GainsConsistent double‑digit SHOP same‑store NOI and rising occupancy bolster recurring cash flows and pricing power in Ventas' core operating segment. Strong occupancy and RevPOR gains drive operating leverage and margin expansion, supporting durable FFO growth and reduced vacancy risk.
Improving Cash Generation And FCF TrendOperating cash flow and free cash flow have trended up through 2025 and TTM, with operating cash flow roughly 1.2x reported net income. Strengthening cash generation supports dividend coverage, reinvestment and acquisitions, underpinning long‑term capital allocation flexibility despite incomplete conversion to FCF.
Strong Liquidity And Capital FlexibilityRecord liquidity, meaningful equity raises and an expanded $3B ATM materially enhance Ventas' ability to fund accretive senior housing investments, cover lease‑ups and deploy opportunistically without immediate reliance on volatile debt markets, improving strategic optionality over coming quarters.
Bears Say
Meaningful Leverage And Debt Reporting InconsistencyLeverage remains elevated historically and, despite improvement, still increases interest‑rate and refinancing sensitivity. A TTM debt reporting inconsistency reduces confidence in leverage metrics and complicates assessment of balance sheet headroom, constraining durable financial flexibility and risk tolerance.
Negative Gross Profit In Latest PeriodsNegative gross profit in 2025 and TTM signals elevated direct costs or reclassifications that compress top‑line economics. Reliance on operating‑level NOI to offset gross losses raises execution risk; if direct costs persist, it could pressure sustainable FFO, dividend support and reinvestment capacity.
Portfolio Stabilization And Lease‑up Execution RiskAcquisitions with sub‑stabilized occupancy and recent deliveries require lease‑ups and CapEx to reach targeted yields. Prolonged stabilization timelines or slower resident intake can delay cash flow realization, increase near‑term operating costs, and reduce the pace at which acquisitions contribute to durable FFO growth.
Ventas News
VEN FAQ
What was Ventas’s price range in the past 12 months?
Ventas lowest stock price was €56.16 and its highest was €87.98 in the past 12 months.
What is Ventas’s market cap?
Ventas’s market cap is €43.98B.
When is Ventas’s upcoming earnings report date?
Ventas’s upcoming earnings report date is Jul 29, 2026 which is today.
How were Ventas’s earnings last quarter?
Currently, no data Available
Is Ventas overvalued?
According to Wall Street analysts Ventas’s price is currently Overvalued.
Does Ventas pay dividends?
Ventas does not currently pay dividends.
What is Ventas’s EPS estimate?
Ventas’s EPS estimate is 0.12.
How many shares outstanding does Ventas have?
Ventas has 486,169,700 shares outstanding.
What happened to Ventas’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ventas?
Currently, no hedge funds are holding shares in DE:VEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ventas Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€87.32 (-0.11% Downside)
€87.32 (-0.11% Downside)
Blogger Sentiment
Bullish
DE:VEN Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $197.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
53.63%
12-Months-Change
Fundamentals
Return on Equity
2.00%
Trailing 12-Months
Asset Growth
6.35%
Trailing 12-Months
Company Description
Ventas
As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic healthcare and real estate industries. We stand as one of the world's foremost Real Estate Investment Trusts (REITs), utilizing financial capital to unlock property value. Our partnerships extend to leading care providers, developers, research and medical institutions, innovators, and healthcare organizations, all of whom benefit from the significant demographic trend of an aging population. For over two decades, Ventas has pursued a steadfast and effective strategy: maintaining a high-quality, diverse portfolio of assets and varied capital streams to skillfully navigate market fluctuations. A dedicated and experienced team collaborates with industry-leading partners to generate consistent, increasing cash flows and superior returns on a strong balance sheet, ultimately enriching Ventas's shareholders. As of September 30, 2020, Ventas either owned outright or managed through unconsolidated joint ventures approximately 1,200 properties.
VEN Company Deck
VEN Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a strongly positive operational and financial momentum driven by SHOP: double-digit SHOP NOI growth, meaningful occupancy and rate improvements, margin expansion, raised FFO guidance, robust liquidity, and an active, relationship-driven acquisition pipeline (including the $540M Revel value-add acquisition). Risks noted were manageable: Q1 weather-related operating expense pressure, several lease-up assets (including Revel) that need execution, increased transaction competition with cap-rate compression, and dependence on the May–September selling season to sustain full-year targets. On balance, highlights substantially outweighed the lowlights as management increased guidance, strengthened the balance sheet, and articulated a scalable operating platform and pipeline.View all DE:VEN earnings summariesVEN Revenue Breakdown
73.30% SHOP
15.39% OM&R
10.31% NNN
1.00% Non-Segment
VEN Stock 12 Month Forecast
Average Price Target
€87.32
▼(-0.11% Downside)
Technical Analysis
Healthpeak Properties
―
Welltower
―
Omega Healthcare
―
Sabra Healthcare REIT
―
Healthcare Realty Trust
―